Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00843869 · ClinicalTrials.gov registry record
Reversal of Tobacco-Related Sinusitis
A clinical trial of Rhinosinusitis, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 282
- Enrollment target
- 1
- Study location
NCT00843869 is a study of Rhinosinusitis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 282 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00843869, a study of Rhinosinusitis, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 282 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is focused on identifying the prevalence of passive or active smoke exposure and zinc deficiency in a cohort of patients who meet the objective and subjective guidelines for chronic rhinosinusitis set forth by the Sinus and Allergy Health Partnership.
Conditions Studied
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2008-08 |
| Est. Completion | 2015-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00843869
The ClinicalTrials.gov registry entry for NCT00843869 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rhinosinusitis appearing as the primary indexed condition, and to 0 interventions.
NCT00843869 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT00843869 about?
NCT00843869 is a clinical study titled "Reversal of Tobacco-Related Sinusitis". This study is focused on identifying the prevalence of passive or active smoke exposure and zinc deficiency in a cohort of patients who meet the objective and subjective guidelines for chronic rhinosinusitis set forth by the Sinus and Allergy Health Partnership.
What is the current status of trial NCT00843869?
This trial is currently completed. The enrollment target is 282 participants. The study started on 2008-08. Estimated completion is 2015-02.
What conditions does trial NCT00843869 study?
This clinical trial studies the following conditions: Rhinosinusitis.
Who is sponsoring clinical trial NCT00843869?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00843869 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rhinosinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.